SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-221369
Filing Date
2022-08-15
Accepted
2022-08-15 18:09:27
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d301098d10q.htm   iXBRL 10-Q 1428576
2 EX-31.1 d301098dex311.htm EX-31.1 6297
3 EX-31.2 d301098dex312.htm EX-31.2 6248
4 EX-32.1 d301098dex321.htm EX-32.1 6246
  Complete submission text file 0001193125-22-221369.txt   5467526

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20220630.xsd EX-101.SCH 40406
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20220630_cal.xml EX-101.CAL 32882
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20220630_def.xml EX-101.DEF 152556
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20220630_lab.xml EX-101.LAB 346732
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20220630_pre.xml EX-101.PRE 269253
58 EXTRACTED XBRL INSTANCE DOCUMENT d301098d10q_htm.xml XML 782027
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 221167445
SIC: 2834 Pharmaceutical Preparations